NTRA
Price
$172.83
Change
-$6.36 (-3.55%)
Updated
Sep 23 closing price
Capitalization
23.72B
42 days until earnings call
VCYT
Price
$34.15
Change
+$0.22 (+0.65%)
Updated
Sep 23 closing price
Capitalization
2.69B
48 days until earnings call
Interact to see
Advertisement

NTRA vs VCYT

Header iconNTRA vs VCYT Comparison
Open Charts NTRA vs VCYTBanner chart's image
Natera
Price$172.83
Change-$6.36 (-3.55%)
Volume$1.75M
Capitalization23.72B
Veracyte
Price$34.15
Change+$0.22 (+0.65%)
Volume$748.17K
Capitalization2.69B
NTRA vs VCYT Comparison Chart in %
Loading...
NTRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NTRA vs. VCYT commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTRA is a StrongBuy and VCYT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (NTRA: $172.83 vs. VCYT: $34.15)
Brand notoriety: NTRA and VCYT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NTRA: 133% vs. VCYT: 47%
Market capitalization -- NTRA: $23.72B vs. VCYT: $2.69B
NTRA [@Medical Specialties] is valued at $23.72B. VCYT’s [@Medical Specialties] market capitalization is $2.69B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $10.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTRA’s FA Score shows that 0 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • NTRA’s FA Score: 0 green, 5 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, NTRA is a better buy in the long-term than VCYT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTRA’s TA Score shows that 3 TA indicator(s) are bullish while VCYT’s TA Score has 4 bullish TA indicator(s).

  • NTRA’s TA Score: 3 bullish, 6 bearish.
  • VCYT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VCYT is a better buy in the short-term than NTRA.

Price Growth

NTRA (@Medical Specialties) experienced а -1.25% price change this week, while VCYT (@Medical Specialties) price change was +5.79% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.43%. For the same industry, the average monthly price growth was +3.59%, and the average quarterly price growth was +23.15%.

Reported Earning Dates

NTRA is expected to report earnings on Nov 05, 2025.

VCYT is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Medical Specialties (+0.43% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTRA($23.7B) has a higher market cap than VCYT($2.69B). NTRA YTD gains are higher at: 9.179 vs. VCYT (-13.763). VCYT has higher annual earnings (EBITDA): 52M vs. NTRA (-211.86M). NTRA has more cash in the bank: 1.02B vs. VCYT (321M). VCYT has less debt than NTRA: VCYT (50.6M) vs NTRA (196M). NTRA has higher revenues than VCYT: NTRA (1.96B) vs VCYT (479M).
NTRAVCYTNTRA / VCYT
Capitalization23.7B2.69B882%
EBITDA-211.86M52M-407%
Gain YTD9.179-13.763-67%
P/E RatioN/A100.44-
Revenue1.96B479M410%
Total Cash1.02B321M317%
Total Debt196M50.6M387%
FUNDAMENTALS RATINGS
NTRA vs VCYT: Fundamental Ratings
NTRA
VCYT
OUTLOOK RATING
1..100
1219
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
75
Overvalued
PROFIT vs RISK RATING
1..100
4297
SMR RATING
1..100
9689
PRICE GROWTH RATING
1..100
4647
P/E GROWTH RATING
1..100
10055
SEASONALITY SCORE
1..100
7541

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NTRA's Valuation (63) in the Biotechnology industry is in the same range as VCYT (75). This means that NTRA’s stock grew similarly to VCYT’s over the last 12 months.

NTRA's Profit vs Risk Rating (42) in the Biotechnology industry is somewhat better than the same rating for VCYT (97). This means that NTRA’s stock grew somewhat faster than VCYT’s over the last 12 months.

VCYT's SMR Rating (89) in the Biotechnology industry is in the same range as NTRA (96). This means that VCYT’s stock grew similarly to NTRA’s over the last 12 months.

NTRA's Price Growth Rating (46) in the Biotechnology industry is in the same range as VCYT (47). This means that NTRA’s stock grew similarly to VCYT’s over the last 12 months.

VCYT's P/E Growth Rating (55) in the Biotechnology industry is somewhat better than the same rating for NTRA (100). This means that VCYT’s stock grew somewhat faster than NTRA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NTRAVCYT
RSI
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 5 days ago
74%
Declines
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 28 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
NTRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CPRA26.130.02
+0.09%
Calamos Russell 2000 Str Alt Prt ETF-Apr
CDEI79.50N/A
N/A
Calvert US Large-Cp Div, Eq AndIncETF
BME36.51-0.04
-0.11%
Blackrock Health Sciences Trust
VIOO111.05-0.14
-0.13%
Vanguard S&P Small-Cap 600 ETF
JHI14.16-0.04
-0.28%
John Hancock Investors Trust Capital Stock

NTRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTRA has been loosely correlated with VCYT. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if NTRA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTRA
1D Price
Change %
NTRA100%
-3.55%
VCYT - NTRA
56%
Loosely correlated
+0.65%
GH - NTRA
55%
Loosely correlated
-0.10%
ISRG - NTRA
54%
Loosely correlated
+0.72%
GKOS - NTRA
48%
Loosely correlated
+0.08%
TWST - NTRA
47%
Loosely correlated
-0.61%
More

VCYT and

Correlation & Price change

A.I.dvisor indicates that over the last year, VCYT has been loosely correlated with GH. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if VCYT jumps, then GH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCYT
1D Price
Change %
VCYT100%
+0.65%
GH - VCYT
53%
Loosely correlated
-0.10%
NTRA - VCYT
53%
Loosely correlated
-3.55%
TWST - VCYT
51%
Loosely correlated
-0.61%
ILMN - VCYT
50%
Loosely correlated
-2.09%
A - VCYT
49%
Loosely correlated
-0.31%
More